<?xml version="1.0" encoding="UTF-8"?><rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:wfw="http://wellformedweb.org/CommentAPI/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	>

<channel>
	<title>metabolic syndrome &#8211; BIOENGINEER.ORG</title>
	<atom:link href="https://bioengineer.org/tag/metabolic-syndrome/feed/" rel="self" type="application/rss+xml" />
	<link>https://bioengineer.org</link>
	<description>Bioengineering</description>
	<lastBuildDate>Wed, 24 Dec 2025 16:57:21 +0000</lastBuildDate>
	<language>en-US</language>
	<sy:updatePeriod>
	hourly	</sy:updatePeriod>
	<sy:updateFrequency>
	1	</sy:updateFrequency>
	<generator>https://wordpress.org/?v=7.0</generator>

<image>
	<url>https://bioengineer.org/wp-content/uploads/2019/09/cropped-bioengineering-32x32.png</url>
	<title>metabolic syndrome &#8211; BIOENGINEER.ORG</title>
	<link>https://bioengineer.org</link>
	<width>32</width>
	<height>32</height>
</image> 
<site xmlns="com-wordpress:feed-additions:1">72741379</site>	<item>
		<title>Microbiome Supplements and Metabolic Syndrome in Youth</title>
		<link>https://bioengineer.org/microbiome-supplements-and-metabolic-syndrome-in-youth/</link>
		
		<dc:creator><![CDATA[Bioengineer]]></dc:creator>
		<pubDate>Wed, 24 Dec 2025 16:57:02 +0000</pubDate>
				<category><![CDATA[Health]]></category>
		<category><![CDATA[Bağırsak Mikrobiyotası ve Sağlık** * **Metabolik Sendrom Gençler:** Ana konu]]></category>
		<category><![CDATA[genç popülasyonda metabolik sendrom]]></category>
		<category><![CDATA[GRADE Değerlendirmeli Meta-Analiz]]></category>
		<category><![CDATA[GRADE meta-analysis]]></category>
		<category><![CDATA[İşte içeriğe uygun 5 etiket: **Metabolik Sendrom Gençler]]></category>
		<category><![CDATA[metabolic syndrome]]></category>
		<category><![CDATA[Microbiome supplements]]></category>
		<category><![CDATA[Mikrobiyom Takviyeleri]]></category>
		<category><![CDATA[Pediatric health interventions]]></category>
		<category><![CDATA[Pediatrik Obezite Müdahaleleri]]></category>
		<category><![CDATA[Youth obesity]]></category>
		<guid isPermaLink="false">https://bioengineer.org/microbiome-supplements-and-metabolic-syndrome-in-youth/</guid>

					<description><![CDATA[In recent years, there has been growing concern about the rising prevalence of metabolic syndrome among youth, particularly those who are overweight or obese. This complex condition encompasses a cluster of risk factors including increased blood pressure, high blood sugar levels, excess body fat around the waist, and abnormal cholesterol levels. These risk factors are [&#8230;]]]></description>
		
		
		
		<post-id xmlns="com-wordpress:feed-additions:1">310983</post-id>	</item>
		<item>
		<title>Linking LncRNAs in EVs to Metabolic Syndrome in PCOS</title>
		<link>https://bioengineer.org/linking-lncrnas-in-evs-to-metabolic-syndrome-in-pcos/</link>
		
		<dc:creator><![CDATA[Bioengineer]]></dc:creator>
		<pubDate>Thu, 18 Dec 2025 04:05:03 +0000</pubDate>
				<category><![CDATA[Health]]></category>
		<category><![CDATA[extracellular vesicles]]></category>
		<category><![CDATA[LncRNAs]]></category>
		<category><![CDATA[Makalenin içeriğine ve anahtar kelimelerine göre en uygun 5 etiket: **PCOS]]></category>
		<category><![CDATA[metabolic syndrome]]></category>
		<category><![CDATA[Women's Health** **Açıklama:** 1. **PCOS:** Makalenin temel odağı Polikistik Over Sendromu olduğu için en kritik etiket. 2. **Metabolic Syndrome:** PCOS ile güç]]></category>
		<guid isPermaLink="false">https://bioengineer.org/linking-lncrnas-in-evs-to-metabolic-syndrome-in-pcos/</guid>

					<description><![CDATA[In a groundbreaking investigation uncovering the intricate relationship between plasma extracellular vesicles (EVs), long non-coding RNAs (lncRNAs), and the metabolic syndrome associated with polycystic ovary syndrome (PCOS), researchers Wu and Mao have ventured into a highly relevant area of study that intertwines reproductive health and metabolic disorder. The implications of this research extend beyond the [&#8230;]]]></description>
		
		
		
		<post-id xmlns="com-wordpress:feed-additions:1">309047</post-id>	</item>
		<item>
		<title>Understanding Metabolic Dysfunction in Indian Liver Disease</title>
		<link>https://bioengineer.org/understanding-metabolic-dysfunction-in-indian-liver-disease/</link>
		
		<dc:creator><![CDATA[Bioengineer]]></dc:creator>
		<pubDate>Sat, 25 Oct 2025 17:08:32 +0000</pubDate>
				<category><![CDATA[Health]]></category>
		<category><![CDATA[Indian Populations]]></category>
		<category><![CDATA[MAP Study]]></category>
		<category><![CDATA[metabolic dysfunction-associated steatotic liver disease (MASLD)]]></category>
		<category><![CDATA[metabolic syndrome]]></category>
		<category><![CDATA[public health strategies]]></category>
		<guid isPermaLink="false">https://bioengineer.org/understanding-metabolic-dysfunction-in-indian-liver-disease/</guid>

					<description><![CDATA[In a compelling and insightful letter to the editor, researchers Bose, Sridharan, and Gupta have addressed critical elements regarding Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD) within the context of Indian populations. This letter follows the publication of the MAP Study, which sought to create a comprehensive profile of MASLD across diverse demographics in India. The [&#8230;]]]></description>
		
		
		
		<post-id xmlns="com-wordpress:feed-additions:1">286848</post-id>	</item>
		<item>
		<title>Refining Metabolic Syndrome Cut-offs in Type 2 Diabetes</title>
		<link>https://bioengineer.org/refining-metabolic-syndrome-cut-offs-in-type-2-diabetes/</link>
		
		<dc:creator><![CDATA[Bioengineer]]></dc:creator>
		<pubDate>Fri, 24 Oct 2025 16:01:40 +0000</pubDate>
				<category><![CDATA[Health]]></category>
		<category><![CDATA[cardio-metabolic indices]]></category>
		<category><![CDATA[diagnostic criteria]]></category>
		<category><![CDATA[metabolic syndrome]]></category>
		<category><![CDATA[patient care optimization]]></category>
		<category><![CDATA[Type 2 diabetes]]></category>
		<guid isPermaLink="false">https://bioengineer.org/refining-metabolic-syndrome-cut-offs-in-type-2-diabetes/</guid>

					<description><![CDATA[In a recent landmark study published in BMC Endocrine Disorders, researchers centered around H. Bazyar and colleagues tackled the pressing issue of diagnosing metabolic syndrome in patients with type 2 diabetes. The study highlights a critical area within endocrinology, addressing how optimal cut-offs for cardio-metabolic indices can enhance diagnostic accuracy. This research shows concerning parallels [&#8230;]]]></description>
		
		
		
		<post-id xmlns="com-wordpress:feed-additions:1">286400</post-id>	</item>
	</channel>
</rss>
